Big news...
"Late Thursday, the government announced orders for intravenous versions of Tamiflu and Relenza, which are much cheaper — a development that could force shares of BioCryst to give up some of their gains on Friday. "
http://www.nytimes.com/2009/11/06/business/06drug.html?_r=1
Add to My Watchlist
What is My Watchlist?